Oak Park, IL, United States of America

John S Coon

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1997-2018

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: John S Coon: Pioneering Diagnostics in Lung Cancer Prognosis

Introduction

John S Coon, an innovative inventor based in Oak Park, Illinois, has made significant contributions to cancer diagnostics, particularly in non-small cell lung cancer (NSCLC). With a total of ten patents to his name, Coon's work on identifying prognostic factors for patients with lung cancer showcases his dedication to enhancing patient care and outcomes.

Latest Patents

Coon's latest patents include groundbreaking diagnostic methods for determining the prognosis of non-small cell lung cancer. His inventions focus on identifying early-stage NSCLC patients who may face unfavorable or favorable prognoses for recurrence following surgical resection. The methods primarily utilize chromosomal copy number abnormalities for prognostic classification, employing fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to analyze patient samples.

One key invention revolves around assessing specific chromosomal loci, combining various classifiers to enhance prognostic accuracy. These classifiers are designed to identify patients at higher risk of recurrence, and thus, guide clinical decisions regarding treatment plans, including the use of neoadjuvant or adjuvant chemotherapy.

Career Highlights

Throughout his career, John S Coon has worked at prominent institutions, including Abbott Laboratories Corporation and Rush-Presbyterian-St. Luke's Medical Center. His tenure at these organizations has allowed him to influence the field of cancer diagnostics significantly and apply his innovative methods in real-world clinical settings.

Collaborations

Coon has collaborated with notable colleagues, including Larry E Morrison and Mannarsamy Balasubramanian. These collaborations have facilitated the advancement of his diagnostic techniques, combining their expertise to improve cancer prognosis assessments further.

Conclusion

John S Coon's contributions to the field of cancer diagnostics through his innovative inventions highlight the importance of research and development in improving patient outcomes. His dedication to identifying critical prognostic factors in non-small cell lung cancer underscores the significant impact that inventive minds can have in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…